World News: 09:30 GMT Wednesday 11th September 2019. [Zealand Pharma via Globe Newswire via SPi World News]
Following the registration of the New Shares with the Danish Business Authority, Zealand's share capital amounts to DKK 35,806,290 divided into 35,806,290 shares with a nominal value of DKK 1 each.
The New Shares rank with Zealand's existing shares and carry the same dividend and other rights. Each New Share carries one vote at Zealand's general meetings. Zealand only has one class of shares.
The New Shares have been issued today and are expected to be admitted to trading on Nasdaq Copenhagen on September 12, 2019 in Zealand's permanent ISIN code DK0060257814.
The amendments to Zealand's articles of association required by the capital increase have been registered today with the Danish Business Authority.
Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit or follow Zealand on LinkedIn or Twitter @ZealandPharma.
Globe Newswire: 09:30 GMT Wednesday 11th September 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.